569 related articles for article (PubMed ID: 8615355)
1. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopheryl acetate preparations.
Winklhofer-Roob BM; van't Hof MA; Shmerling DH
Am J Clin Nutr; 1996 May; 63(5):722-8. PubMed ID: 8615355
[TBL] [Abstract][Full Text] [Related]
2. Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals.
Winklhofer-Roob BM; Tuchschmid PE; Molinari L; Shmerling DH
Am J Clin Nutr; 1996 May; 63(5):717-21. PubMed ID: 8615354
[TBL] [Abstract][Full Text] [Related]
3. Water-miscible tocopherol is not superior to fat-soluble preparation for vitamin E absorption in cystic fibrosis.
Soltani-Frisk S; Gronowitz E; Andersson H; Strandvik B
Acta Paediatr; 2001 Oct; 90(10):1112-5. PubMed ID: 11697419
[TBL] [Abstract][Full Text] [Related]
4. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E.
Burton GW; Traber MG; Acuff RV; Walters DN; Kayden H; Hughes L; Ingold KU
Am J Clin Nutr; 1998 Apr; 67(4):669-84. PubMed ID: 9537614
[TBL] [Abstract][Full Text] [Related]
5. Comparison of plasma alpha and gamma tocopherol levels following chronic oral administration of either all-rac-alpha-tocopheryl acetate or RRR-alpha-tocopheryl acetate in normal adult male subjects.
Baker H; Handelman GJ; Short S; Machlin LJ; Bhagavan HN; Dratz EA; Frank O
Am J Clin Nutr; 1986 Mar; 43(3):382-7. PubMed ID: 3953477
[TBL] [Abstract][Full Text] [Related]
6. [Supplementation of DL-alpha-tocopherol acetate in children with chronic cholestasis and vitamin E deficiency].
Velasco Benítez CA; Rangel de la Garza SD; García Aranda JA
Rev Gastroenterol Mex; 1996; 61(1):14-8. PubMed ID: 8685584
[TBL] [Abstract][Full Text] [Related]
7. Serum concentrations of alpha-tocopherol after ingestion of various vitamin E preparations.
Horwitt MK; Elliott WH; Kanjananggulpan P; Fitch CD
Am J Clin Nutr; 1984 Aug; 40(2):240-5. PubMed ID: 6465056
[TBL] [Abstract][Full Text] [Related]
8. Infants discriminate between natural and synthetic vitamin E.
Stone WL; LeClair I; Ponder T; Baggs G; Reis BB
Am J Clin Nutr; 2003 Apr; 77(4):899-906. PubMed ID: 12663289
[TBL] [Abstract][Full Text] [Related]
9. Biokinetics in humans of RRR-alpha-tocopherol: the free phenol, acetate ester, and succinate ester forms of vitamin E.
Cheeseman KH; Holley AE; Kelly FJ; Wasil M; Hughes L; Burton G
Free Radic Biol Med; 1995 Nov; 19(5):591-8. PubMed ID: 8529918
[TBL] [Abstract][Full Text] [Related]
10. Plasma alpha-tocopherol profiles in sheep after oral administration of dl-alpha-tocopheryl acetate and d-alpha-tocopheryl succinate.
Hidiroglou M; Singh K
J Dairy Sci; 1991 Aug; 74(8):2718-23. PubMed ID: 1918545
[TBL] [Abstract][Full Text] [Related]
11. Relative bioavailabilities of natural and synthetic vitamin E formulations containing mixed tocopherols in human subjects.
Chopra RK; Bhagavan HN
Int J Vitam Nutr Res; 1999 Mar; 69(2):92-5. PubMed ID: 10218145
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of natural (RRR-alpha-tocopheryl acetate) and synthetic (all-rac-alpha-tocopheryl acetate) vitamin E fortification in the diet or drinking water of weanling pigs.
Wilburn EE; Mahan DC; Hill DA; Shipp TE; Yang H
J Anim Sci; 2008 Mar; 86(3):584-91. PubMed ID: 18156353
[TBL] [Abstract][Full Text] [Related]
13. Development of vitamin-E-status of premature infants after intravenous application of all-rac-alpha-tocopheryl acetate.
Schwalbe P; Büttner P; Elmadfa I
Int J Vitam Nutr Res; 1992; 62(1):9-14. PubMed ID: 1587713
[TBL] [Abstract][Full Text] [Related]
14. RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus.
Fuller CJ; Chandalia M; Garg A; Grundy SM; Jialal I
Am J Clin Nutr; 1996 May; 63(5):753-9. PubMed ID: 8615360
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E intake, α-tocopherol levels and pulmonary function in children and adolescents with cystic fibrosis.
Woestenenk JW; Broos N; Stellato RK; Arets HG; van der Ent CK; Houwen RH
Br J Nutr; 2015 Apr; 113(7):1096-101. PubMed ID: 25762411
[TBL] [Abstract][Full Text] [Related]
16. Plasma RRR-alpha-tocopherol concentrations are lower in smokers than in non-smokers after ingestion of a similar oral load of this antioxidant vitamin.
Munro LH; Burton G; Kelly FJ
Clin Sci (Lond); 1997 Jan; 92(1):87-93. PubMed ID: 9038597
[TBL] [Abstract][Full Text] [Related]
17. Influence of supplementation of all-rac-alpha-tocopheryl acetate preweaning and vitamin C postweaning on alpha-tocopherol and immune responses of piglets.
Lauridsen C; Jensen SK
J Anim Sci; 2005 Jun; 83(6):1274-86. PubMed ID: 15890805
[TBL] [Abstract][Full Text] [Related]
18. Short-term changes in erythrocyte alpha-tocopherol content of vitamin E-deficient patients with cystic fibrosis.
Winklhofer-Roob BM; Shmerling DH; Schimek MG; Tuchschmid PE
Am J Clin Nutr; 1992 Jan; 55(1):100-3. PubMed ID: 1728808
[TBL] [Abstract][Full Text] [Related]
19. alpha-Tocopherol concentrations in serum and tissues of sheep fed different sources of vitamin E.
Ochoa L; McDowell LR; Williams SN; Wilkinson N; Boucher J; Lentz EL
J Anim Sci; 1992 Aug; 70(8):2568-73. PubMed ID: 1506319
[TBL] [Abstract][Full Text] [Related]
20. Impaired resistance to oxidation of low density lipoprotein in cystic fibrosis: improvement during vitamin E supplementation.
Winklhofer-Roob BM; Ziouzenkova O; Puhl H; Ellemunter H; Greiner P; Müller G; van't Hof MA; Esterbauer H; Shmerling DH
Free Radic Biol Med; 1995 Dec; 19(6):725-33. PubMed ID: 8582644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
